Previous 10 | Next 10 |
ViewRay Announces Preliminary Fourth Quarter and Full Year 2021 Results PR Newswire CLEVELAND , Jan. 10, 2022 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced preliminary financial results for the fourth quarter and full fiscal year e...
ViewRay to Participate in the 40th Annual J.P. Morgan Healthcare Conference PR Newswire CLEVELAND , Dec. 23, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced its participation in the 40th Annual J.P. Morgan Healthcare Conference. ViewRay's ma...
Gainers: Spruce Biosciences (NASDAQ:SPRB) +30%. Coherus BioSciences (NASDAQ:CHRS) +11%. TPI Composites (NASDAQ:TPIC) +6%. Lyell Immunopharma (NASDAQ:LYEL) +4%. Aquestive Therapeutics (NASDAQ:AQST) +4%. Losers: Adagio Therapeutics (NASDAQ:ADGI) -5%. Leslie's (NASDAQ:LESL) -3%. Rivian Automotiv...
ViewRay (NASDAQ:VRAY) announced that the FDA granted 510(k) clearance for certain MRI-guided radiation therapy features designed to improve workflow and widen clinical use. The next-gen features greenlighted by the regulator enhance on-table adaptive workflow and expand clinical utility, the ...
ViewRay Receives 510(k) Clearance on Next Generation of MRIdian MRI-Guided Radiation Therapy Features MRIdian A3i and Brain Treatment Package Enhance On-Table Adaptive Workflow and Expand Clinical Utility PR Newswire CLEVELAND , Dec. 15, 2021 /PRNewswire/ --&...
Northside Hospital Chooses MRIdian System to Expand Advanced Radiation Therapy Treatment Services Northside Cancer Institute will be first in Georgia to offer MRI-guided radiation therapy system PR Newswire CLEVELAND , Dec. 7, 2021 /PRNewswire/ -- ViewRay, In...
ViewRay Announces MRIdian MR-Guided Radiation Therapy Surpasses 2,300 Pancreatic Cancer Patients Treated Worldwide With 46 Centers in 16 Countries, Clinical Teams are Changing the Paradigm for Pancreatic Cancer with MRIdian. PR Newswire CLEVELAND , Nov. 24, 202...
Gainers: MediciNova (NASDAQ:MNOV) +27%. Puma Biotechnology (NASDAQ:PBYI) +6%. GoHealth (NASDAQ:GOCO) +5%. Chindata Group Holdings Limited (NASDAQ:CD) +4%. Nutanix (NASDAQ:NTNX) +4%. Losers: Autodesk (NASDAQ:ADSK) -13%. Esperion Therapeutics (NASDAQ:ESPR) -10%. Cl...
ViewRay Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in connection with Public Offering of Common Stock PR Newswire CLEVELAND , Nov. 23, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, whic...
ViewRay Announces Closing of Public Offering of Common Stock PR Newswire CLEVELAND , Nov. 19, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer ...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...